Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/19815
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKothekar, V-
dc.contributor.authorSahi, Shakti-
dc.contributor.authorMishra, Jyoti-
dc.date.accessioned2013-07-16T07:04:45Z-
dc.date.available2013-07-16T07:04:45Z-
dc.date.issued2000-04-
dc.identifier.issn0975-0959 (Online); 0301-1208 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/19815-
dc.description86-96en_US
dc.description.abstractWe have studied the conformational flexibility of three 5-keto-substituted 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofurans (DHDMBFs) which show dual cyclooxygenase (COX) and 5-lipoxygenase (LOX) inhibition and are potential candidates as antiinflammatory agents and analgesics. The conformations were studied by systematic search, molecular mechanics (MM) and simulated annealing molecular dynamics (SAMD) technique have also studied several structure based parameters and distribution of molecular electrostatic potential (MEP) around these molecules. All the three compounds were docked in the active cavity of cyclooxygenase-2 (COX-2) using graphical and energy grid search techniques. The complex geometries were optimized by MM. The results on conformation al flexibility, inter-atomic distances and angles, MEP distribution and points of contacts with peptide side chains in active cavity have been used to understand the mechanistic cause of differential action of these molecules.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rightsCC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBB Vol.37(2) [April 2000]en_US
dc.titleEnzyme selectivity of new cyclooxygenase-2/5 lipoxygenase inhibitors using molecular modeling approachen_US
dc.typeArticleen_US
Appears in Collections: IJBB Vol.37(2) [April 2000]

Files in This Item:
File Description SizeFormat 
IJBB 37(2) 86-96.pdf2.14 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.